CD30 CAR T-cells Post AutoHSCT for Poor-risk Hodgkin Lymphoma
Clinical trial NCT06617286 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06617286
- Sponsor
- New York Medical College
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-12-01
- Primary completion
- 2039-12-31
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.